ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Evaluation of a Mandibular Advancement Device in the Treatment of Obstructive Sleep Apnea Syndrome

This study is currently recruiting participants.
Verified by University Hospital, Rouen, September 2005

Sponsored by: University Hospital, Rouen
Information provided by: University Hospital, Rouen
ClinicalTrials.gov Identifier: NCT00213434
  Purpose

The purpose of this study is to determine if the mandibular advancement by Herbst device is effective in the treatment of moderate obstructive sleep apnea patients.


Condition Intervention
Obstructive Sleep Apnea
Device: Herbst oral appliance

MedlinePlus related topics:   Sleep Apnea   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title:   Prospective Evaluation of Mandibular Advancement by Herbst Device in the Treatment of Moderate Obstructive Sleep Apnea Syndrome

Further study details as provided by University Hospital, Rouen:

Primary Outcome Measures:
  • Comparison of polysomnographic data after 3 months of treatment by oral appliance in 2 groups: one with Herbst device adjusted in maximal mandibular advancement and a placebo group

Secondary Outcome Measures:
  • Efficacy on clinical symptoms
  • Tolerance of the oral appliance
  • Identification of predictive factors of efficacy
  • Feasibility of this therapeutic method

Study Start Date:   November 2001

  Eligibility
Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Moderate sleep apnea syndrome (10 < Respiratory Disorder Index < 30)
  • Body mass index (BMI) < 35 Kg/m2
  • Able to give their informed consent

Exclusion Criteria:

  • Pregnant women
  • Professional drivers requiring continuous positive airway pressure (CPAP) treatment
  • Psychiatric disorders, and patients unable to realise to study
  • Severe respiratory pathology which could interfere with the study
  • Morpheic epilepsy
  • Benzodiazepines intake
  • Chronic nasal obstruction
  • Ear, nose, and throat (ENT) pathology requiring surgery
  • Previous uvulopalatoplasty surgery
  • Temporomandibular joint pathology
  • Gum disease
  • Insufficient number of teeth to apply the oral appliance
  • Mobile teeth
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00213434

Contacts
Contact: PORTIER PF Florence, MD     florence.portier@chu-rouen.fr    

Locations
France
CHU de ROUEN     Recruiting
      ROUEN, France, 76031
      Contact: PORTIER PF FLORENCE, MD     33 2 3288 90 83     florence.portier@chu-rouen.fr    

Sponsors and Collaborators
University Hospital, Rouen

Investigators
Principal Investigator:     PORTIER PF Florence, MD     CHU de ROUEN    
  More Information

Study ID Numbers:   2000/055 HP
First Received:   September 13, 2005
Last Updated:   June 23, 2006
ClinicalTrials.gov Identifier:   NCT00213434
Health Authority:   France: Afssaps - French Health Products Safety Agency

Keywords provided by University Hospital, Rouen:
prospective  
randomized  
polysomnography  
orthodontic appliance, removable  

Study placed in the following topic categories:
Signs and Symptoms
Sleep Apnea Syndromes
Respiratory Tract Diseases
Apnea
Respiration Disorders
Sleep Apnea, Obstructive
Dyssomnias
Sleep Disorders
Signs and Symptoms, Respiratory
Sleep Disorders, Intrinsic

Additional relevant MeSH terms:
Nervous System Diseases

ClinicalTrials.gov processed this record on September 05, 2008




Links to all studies - primarily for crawlers